Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Mar 18;65(4):e00083-21.
doi: 10.1128/AAC.00083-21. Print 2021 Mar 18.

Reply to Dorgham et al., "Considering Personalized Interferon Beta Therapy for COVID-19"

Effat Davoudi-Monfared  1 , Hossein Khalili  2
Affiliations
Comment

Reply to Dorgham et al., "Considering Personalized Interferon Beta Therapy for COVID-19"

Effat Davoudi-Monfared et al. Antimicrob Agents Chemother. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Dorgham K, Neumann AU, Decavele M, Luyt C-E, Yssel H, Gorochov G. 2021. Considering personalized interferon beta therapy for COVID-19. Antimicrob Agents Chemother 65:e00065-21. doi:10.1128/AAC.00065-21. - DOI - PMC - PubMed
    1. Davoudi-Monfared E, Rahmani H, Khalili H, Hajiabdolbaghi M, Salehi M, Abbasian L, Kazemzadeh H, Yekaninejad MS. 2020. A randomized clinical trial of the efficacy and safety of interferon beta-1a in treatment of severe COVID-19. Antimicrob Agents Chemother 64:e01061-20. doi:10.1128/AAC.01061-20. - DOI - PMC - PubMed
    1. Crow MK, Ronnblom L. 2019. Type I interferons in host defence and inflammatory diseases. Lupus Sci Med 6:e000336. doi:10.1136/lupus-2019-000336. - DOI - PMC - PubMed
    1. Qiu K, Liu B, Li S-Y, Li H, Chen Z-W, Luo A-R, Peng M-L, Ren H, Hu P. 2018. Systematic review with meta‐analysis: combination treatment of regimens based on pegylated interferon for chronic hepatitis B focusing on hepatitis B surface antigen clearance. Aliment Pharmacol Ther 47:1340–1348. doi:10.1111/apt.14629. - DOI - PubMed
    1. Strayer DR, Dickey R, Carter WA. 2014. Sensitivity of SARS/MERS CoV to interferons and other drugs based on achievable serum concentrations in humans. Infect Disord Drug Targets 14:37–43. doi:10.2174/1871526514666140713152858. - DOI - PubMed

Substances

LinkOut - more resources